Why Pharmacogenomics (PGx)?

When a health care provider is considering prescribing a drug, knowledge of a patient’s genotype may be used to aid in determining a therapeutic strategy, determining an appropriate dosage, or assessing the likelihood of benefit or toxicity. -Food and Drug Administration

The Problem

  • Side Effects & Adverse Drug Reactions (ADRs)
  • Non-Adherence to Prescription Drug Regimen
  • Unnecessary Healthcare Costs Associated with Sub-Optimal Drug Regimens
  • Hospital & ER Visits Due to Severe Adverse Reactions

The Solution

Improve Medication Efficacy
By considering an individual’s genetic variations, providers are able to select medications that are more likely to be effective or that specific individual.
Reduced Adverse Drug Reactions
Pharmacogenomics helps identify individuals who may be at a higher risk of experiencing adverse drug reactions due to genetic variations.
Reduced Unnecessary Healthcare Costs
Pharmacogenomic testing can potentially save healthcare costs in the long run. By avoiding ineffective medications or those linked to adverse reactions, unnecessary hospitalizations and additional medical interventions may be prevented.
Streamline Treatment Plans
Pharmacogenomic data is able to help predict how an individual may respond to certain medications, allowing for more target and efficient treatment strategies.

How Pharmacogenomics Can Help?

Pharmacogenomics can play an important role in identifying responders and nonresponders to medications, avoiding adverse events, and optimizing drug dose. - Food and Drug Administration

Bridge Core Principles

Improving patient outcomes and ensuring individualized care for each patient that we serve is at the center of what we do. Our success is measured by our ability to directly enhance patient care by providing useful and innovative solutions to physicians and ensuring they have the most accurate diagnostics available.
Innovation
  • Cutting-edge laboratory technology
  • Propriety novel test methodologies
  • Population Health Management
  • Advanced workflow solutions
Integrity
  • Commitment to quality
  • Dedication to compliance
  • Integrity of clinical data
  • Devotion to corporate responsibility

The Bridge Population Health Dashboard (PHD)

Pharmacogenomics allows providers, health systems, payers, and PBMs to assess the viability of Pharmacogenomics testing in their patient population. Our proprietary software system ingests patient medication regimen data and compares it to the drug-gene interaction tables outlined by CMS (Centers for Medicare & Medicaid Services) to identify potential risk and medical necessity of Pharmacogenomics testing for every patient in the data set.

The Bridge Ordering Resulting Interface Next Generation (BORING)

Allows for seamless integration of the PHD data to easily identify, order, and retrieve test results for patients that may qualify based on CMS guidelines.
Bridging the gap between diagnostics and therapeutics to improve patient outcomes.
Quick Links
Contact
Bridge Diagnostics LLC
120 Vantis Drive, Suite 570
Aliso Viejo, CA 92656
1.800.803.1611